An Updated Understanding of the Role of YAP in Driving Oncogenic Responses

Giampaolo Morciano1, Bianca Vezzani1, Sonia Missiroli1

  • 1Laboratory for Technologies of Advanced Therapies (LTTA), Section of Experimental Medicine, Department of Medical Science, University of Ferrara, 44121 Ferrara, Italy.

Cancers
|July 2, 2021
PubMed

Insights

Yes-associated protein (YAP) is a key oncogene in cancer, regulating tumor growth and metastasis. Understanding YAP

Area of Science:

  • Oncology and Molecular Biology
  • Cancer Signaling Pathways
  • Cellular Regulation

Background:

  • Yes-associated protein (YAP) is a potent oncogene central to cancer signaling.
  • Nuclear YAP drives oncogenic processes like cell transformation, tumor growth, migration, and metastasis.
  • YAP also mediates crucial interactions between immune and cancer cells.

Purpose of the Study:

  • To review the current knowledge on YAP's role in cancer signaling.
  • To differentiate YAP from WWTR1/TAZ and identify its upstream regulators.
  • To explore YAP's involvement in various cancer stages, immune-cancer crosstalk, and therapeutic strategies.

Main Methods:

  • Literature review and synthesis of existing research on YAP.
  • Comparative analysis of YAP and WWTR1/TAZ functions.
  • Examination of YAP's role in cancer progression and therapeutic interventions.

Main Results:

  • YAP's complex regulatory mechanisms and its cytoplasmic retention offer novel therapeutic insights.
  • YAP's distinct functions compared to WWTR1/TAZ are highlighted.
  • YAP's multifaceted role across cancer stages and its interaction with therapies are detailed.

Conclusions:

  • YAP is a critical oncogene with diverse roles in cancer development and progression.
  • Understanding YAP regulation and localization is key to developing new anticancer treatments.
  • Targeting YAP, alone or in combination with existing therapies, presents promising translational strategies.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.5K